Measuring Spatial Access of Vulnerable Population to HIV Testing Facilities in the Baton Rouge Metropolitan Statistical Area, Louisiana
AIDS and Behavior · 2024
DOI: 10.1007/s10461-024-04304-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS and Behavior, 2024. Verfasst von Changzhen Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geography and the Environment, University of Alabama, Tuscaloosa, AL, 35401, USA. cwang94@ua.edu. Hauptthemen laut MEDLINE: Health Services Accessibility, Vulnerable Populations, HIV Infections, HIV Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: LSU R. C. West and R. J. Russell Graduate Student Field Research Award.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geography and the Environment, University of Alabama, Tuscaloosa, AL, 35401, USA. cwang94@ua.edu.
- Independent Researcher, East Lansing, MI, USA.
- Department of Geography and Anthropology, Louisiana State University, Baton Rouge, LA, 70803, USA.
Förderung
- LSU R. C. West and R. J. Russell Graduate Student Field Research Award
Zitieren
APA
Wang, C., Prigozhina, A., & Leitner, M. (2024). Measuring Spatial Access of Vulnerable Population to HIV Testing Facilities in the Baton Rouge Metropolitan Statistical Area, Louisiana. AIDS and Behavior. https://doi.org/10.1007/s10461-024-04304-3
Vancouver
Wang C, Prigozhina A, Leitner M. Measuring Spatial Access of Vulnerable Population to HIV Testing Facilities in the Baton Rouge Metropolitan Statistical Area, Louisiana. AIDS and Behavior. 2024. doi:10.1007/s10461-024-04304-3
BibTeX
@article{Wang2024,
author = {Wang, Changzhen and Prigozhina, Alina and Leitner, Michael},
title = {Measuring Spatial Access of Vulnerable Population to HIV Testing Facilities in the Baton Rouge Metropolitan Statistical Area, Louisiana},
journal = {AIDS and Behavior},
year = {2024},
doi = {10.1007/s10461-024-04304-3}
}
EUVIMED